313
Participants
Start Date
April 9, 2019
Primary Completion Date
March 7, 2020
Study Completion Date
March 7, 2020
Dapagliflozin
Tablets administered orally once daily. Treatment start within 24h after randomisation for 16 weeks.
Placebo
Tablets administered orally once daily. Treatment start within 24h after randomisation for 16 weeks.
Research Site, Diepkloof, Soweto
Research Site, Copenhagen
Research Site, Hvidovre
Research Site, Hellerup
Research Site, Næstved
Research Site, Odense C
Research Site, Esbjerg
Research Site, Cape Town
Research Site, Cape Town
Research Site, Århus N
Research Site, Randers
Research Site, Hjørring
Research Site, New York
Research Site, Rosedale
Research Site, Buffalo
Research Site, Pittsburgh
Research Site, Abington
Research Site, Falls Church
Research Site, Gangwon-do
Research Site, Burlington
Research Site, Tucker
Research Site, Miami
Research Site, Miami
Research Site, Alexander City
Research Site, Fort Payne
Research Site, Fairhope
Research Site, Mobile
Research Site, Tullahoma
Research Site, Munster
Research Site, Petoskey
Research Site, Kansas City
Research Site, Beverly Hills
Research Site, Torrance
Research Site, Umeå
Research Site, Seattle
Research Site, Stamford
Research Site, New Brunswick
Research Site, Blumenau
Research Site, Porto Alegre
Research Site, São Paulo
Research Site, São Paulo
Research Site, Winnipeg
Research Site, Moncton
Research Site, St. John's
Research Site, Ajax
Research Site, North York
Research Site, Oshawa
Research Site, Scarborough Village
Research Site, Stoney Creek
Research Site, York
Research Site, Gatineau
Research Site, Longueuil
Research Site, Montreal
Research Site, Québec
Research Site, Québec
Research Site, Québec
Research Site, Saint-Georges
Research Site, Svendborg
Research Site, Daito-shi
Research Site, Kobe
Research Site, Matsubara-shi
Research Site, Naha
Research Site, Osaka
Research Site, Sayama-shi,
Research Site, Shunan-shi
Research Site, Takarazuka-shi
Research Site, Lučenec
Research Site, Martin
Research Site, Prešov
Research Site, Seoul
Research Site, Seoul
Research Site, Gothenburg
Research Site, Lund
Research Site, Östersund
Research Site, Stockholm
Research Site, Stockholm
Lead Sponsor
AstraZeneca
INDUSTRY